CAMBRIDGE, Mass., April 3 /PRNewswire/ -- Xanthus Pharmaceuticals, Inc., a
privately-held oncology drug development company, today announced that Richard
T. Dean, Ph.D., Chief Executive Officer of Xanthus, will present a corporate
overview at the BIO 2006 Annual International Convention on Monday, April 10th
at 3:30 pm at the McCormick Place Convention Center in Chicago, IL.
About Xanthus Pharmaceuticals, Inc.
Xanthus Pharmaceuticals, Inc. is developing a portfolio of novel,
clinical-stage, small-molecule oncology candidates through a management team
whose accomplished track record encompasses all aspects of drug development,
from discovery through regulatory approval and commercialization. The Company
is applying its expertise both to advance its current pipeline and expand it
into indications of unmet medical need beyond oncology.
Xanthus is headquartered in Cambridge, Massachusetts with an additional
facility in Montreal, Quebec. More information is available at
http://www.xanthus.com.
Contacts:
Kari Watson, MacDougall Biomedical Communications, Inc. --
kwatson@macbiocom.com or (508) 647-0209
John A. McCarthy, Jr., Senior Vice President & CFO, Xanthus
Pharmaceuticals, Inc. -- john.mccarthy@xanthus.com or (617) 225-0522, x 125
SOURCE Xanthus Pharmaceuticals, Inc.
 back to top
Related links:
http://www.xanthus.com
CONTACT:
Kari Watson of MacDougall Biomedical
Communications, Inc., for Xanthus Pharmaceuticals, Inc.,
+1-508-647-0209, kwatson@macbiocom.com; or John A. McCarthy, Jr.,
Senior Vice President & CFO of Xanthus Pharmaceuticals, Inc.,
+1-617-225-0522, ext. 125, john.mccarthy@xanthus.com
|
